De Novo
DEN230090: First To Know Syphilis Test
FDA De Novo · nowdiagnostics · decided Aug 16, 2024
Key facts
| De Novo number | DEN230090 |
|---|---|
| Device name | First To Know Syphilis Test |
| Applicant | nowdiagnostics |
| Product code | SBZ |
| Date received | Dec 27, 2023 |
| Decision date | Aug 16, 2024 |
| Decision | granted (DENG) |
| FDA classification | Class II |
| Review panel | Microbiology |
| FEI number | 3010864358 |
At a glance
- None Later 510(k)s citing this De Novo
- 1–9 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: